GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lombard Medical Technologies PLC (LSE:LMT) » Definitions » Stock Based Compensation

Lombard Medical Technologies (LSE:LMT) Stock Based Compensation : £-0.26 Mil (TTM As of Dec. 2012)


View and export this data going back to . Start your Free Trial

What is Lombard Medical Technologies Stock Based Compensation?

Lombard Medical Technologies's Stock Based Compensation for the six months ended in Dec. 2012 was £-0.26 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2012 was £-0.26 Mil.


Lombard Medical Technologies Stock Based Compensation Historical Data

The historical data trend for Lombard Medical Technologies's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lombard Medical Technologies Stock Based Compensation Chart

Lombard Medical Technologies Annual Data
Trend Sep02 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.25 -0.03 0.23 0.26 -0.26

Lombard Medical Technologies Semi-Annual Data
Sep02 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.25 -0.03 0.23 0.26 -0.26

Lombard Medical Technologies Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2012 was £-0.26 Mil.


Lombard Medical Technologies Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Lombard Medical Technologies's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


Lombard Medical Technologies (LSE:LMT) Business Description

Traded in Other Exchanges
N/A
Address
Lombard Medical Technologies PLC is engaged in the design and development of endovascular stent grafts, their manufacture, and commercialization either directly through the group's own sales force or through a network of local distributors supported by clinical specialists from Lombard Medical. The principal product, the AorfixT AAA stent graft has European CE mark approval for use in patients with high-angle-neck aneurysms of up to 90 degrees. The group has operations in United Kingdom and United States of America.